<?xml version="1.0" encoding="UTF-8"?>
<p>Dosing for telaprevir (according to product labeling): HCV treatment na√Øve patients/relapsers received telaprevir for 12 weeks and Peg-IFN/RBV for 24 or 48 weeks. Again, treatment duration was dependent on patient response after 4 weeks of treatment. Non-responders and patients with compensated cirrhosis were prescribed telaprevir for 12 weeks and Peg-IFN/RBV for 48 weeks.</p>
